With over 19 millions in NIH funding for 2022, M&I PIs rank our department #10 in the Blue Ridge Institute for Medical Research (BRIMR) and maintain our 2021 placement. For 2022, Alice Telesnisky, Ph.D., also ranked #10 PI out of 43,500 PIs! We are so proud of you all!
“The BRIMR standings are widely cited as a measure of scientific vitality, and have been used to examine trends in funding to individual grantees and to academic specialties.” —BRIRM
More information on how this ranking is established and what it means
Every year since 2006, the Blue Ridge Institute for Medical Research (BRIMR), an independent nonprofit organization, has published rankings of institutions, departments, and investigators based on the funding they receive from the US National Institutes of Health (NIH). The BRIMR standings are widely cited as a measure of scientific vitality, and have been used to examine trends in funding to individual grantees and to academic specialties.Though focused on one prosaic, pecuniary aspect of the nation’s biomedical research enterprise, they have the advantage of being quantitative and objective, insofar as the competition for NIH funds is overseen by expert peer reviewers from institutions across the country.
The BRIMR rankings are derived each year from data compiled and released by the NIH shortly after the federal fiscal year closes. The NIH posts these data on its Research Portfolio Online Reporting Tool (RePORT) website in the form of a master Excel spreadsheet file called “Worldwide”. For fiscal 2022, which began on 1 October 2021 and ended on 30 September 2022, this file was posted in late December 2022. It contained tabulated information on more than $36 billion in funding through 65,307 extramural NIH grants or contracts awarded to more than 43,500 Principal Investigators (PIs) that year.
Important aspects of BRIMR rankings are dictated by NIH policy and practice, as reflected in the data posted on NIH RePORT. BRIMR conforms to the NIH’s longstanding policy of crediting only one lead PI and one institution for any given award, even in the case of large consortia, program projects, subcontracts, or multi-PI awards.
NIH neither participates in nor endorses the rankings, which are solely BRIMR’s responsibility; calling them “NIH rankings” can be misleading in that regard.